Angiotensin II type 1 receptor blocking agents in regression of cardiac hypertrophy--how and why?
Paul
B
B
Department of Medicine, JLN Medical College, Ajmer.
Goyal
R K
RK
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006332:Cardiomegaly / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D004359:Drug Therapy, Combination; D006801:Humans; D009206:Myocardium / Q000473:pathology; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology
D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000804:Angiotensin II